Study S002162

A Multicenter Prospective Non-interventional Study Investigating the Treatment Effect of Xultophy® Intensification in a Real World Population With Type 2 Diabetes in United Arab Emirates

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03823339
Acronym: INTENSIFY
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 300
Start: 2019-01-29
Primary completion: 2020-12-14
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:Insulin degludec/liraglutide
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1213-4338

Registered primary outcomes

Change in laboratory measured glycosylated haemoglobin A1c (HbA1c) [From baseline [≤12 weeks prior to treatment initiation [week 0]) to end of study (26-34 weeks)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.